Companies Cryptocurrencies
Guardion Health Sciences Inc
Guardion Health Sciences Inc
Exchange: NasdaqCM
IPO Date: 05/04/2019
CEO: Mr. Michael Favish
Drug Manufacturers General Specialty & Generic Healthcare 🔗
  • GHSI
  • 0.1689
  • 10375020
    market cap
  • 0.00389999
If you bought

shares of Guardion Health Sciences Inc (GHSI) on
You would have made
Old Price $12 Current Price $12

Guardion Health Sciences, Inc. engages in the provision of health care services. The company is headquartered in San Diego, California and currently employs 94 full-time employees. The firm operates through two segments: Medical Foods and Vision Testing Diagnostics. Medical Foods segment develops, formulates and distributes condition-specific medical foods with an initial medical food product on the market under the brand name Lumega-Z that replenishes and restores the macular protective pigment. The company has also developed a technology, the MapcatSF, which measures the macular pigment optical density (MPOD). The company also provides GlaucoCetin, which is the vision-specific medical food designed to support and protect the mitochondrial function of optic nerve cells and improves blood flow in the ophthalmic artery in patients with glaucoma. The Company’s Vision Testing Diagnostics segment operates under the brand name VectorVision. The company specializes in the standardization of contrast sensitivity, glare sensitivity, low contrast acuity and early treatment diabetic retinopathy study (ETDRS) visual acuity testing.

Address: 15150 Avenue of Science Ste 200 San Diego CALIFORNIA 92128

Stay updated.